These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 30506853

  • 1. Does region of origin influence the timing and outcome of first-line antiretroviral therapy in France?
    Gatey C, Brun A, Hamet G, Diamantis S, Sellier P, Bouchaud O, Garrait V, Rozenbaum W, Molina JM, Abgrall S, COREVIH Ile de France Est Research Group.
    HIV Med; 2019 Feb; 20(2):175-181. PubMed ID: 30506853
    [Abstract] [Full Text] [Related]

  • 2. Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
    de Monteynard LA, Matheron S, Gilquin J, Pavie J, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Simon A, Mahamat A, Dray-Spira R, Costagliola D, Abgrall S, FHDH-ANRS CO4.
    AIDS; 2016 Sep 10; 30(14):2235-46. PubMed ID: 27428741
    [Abstract] [Full Text] [Related]

  • 3. Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
    de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S, French Hospital Database on HIV.
    PLoS One; 2015 Sep 10; 10(3):e0118492. PubMed ID: 25734445
    [Abstract] [Full Text] [Related]

  • 4. Timing of combined antiretroviral treatment initiation in male and female migrants living with HIV in Western Europe.
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
    AIDS; 2017 Mar 27; 31(6):835-846. PubMed ID: 28272136
    [Abstract] [Full Text] [Related]

  • 5. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
    HIV Med; 2018 Jan 27; 19(1):42-48. PubMed ID: 28741837
    [Abstract] [Full Text] [Related]

  • 6. Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
    Seng R, Ghislain M, Girard PM, Cotte L, Meybeck A, Raffi F, Abgrall S, Yazdanpanah Y, Goujard C, Dray-Spira R, Meyer L.
    AIDS; 2017 Jun 01; 31(9):1323-1332. PubMed ID: 28492394
    [Abstract] [Full Text] [Related]

  • 7. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
    Mocroft A, Phillips AN, Gatell J, Ledergerber B, Fisher M, Clumeck N, Losso M, Lazzarin A, Fatkenheuer G, Lundgren JD, EuroSIDA study group.
    Lancet; 2007 Aug 04; 370(9585):407-13. PubMed ID: 17659333
    [Abstract] [Full Text] [Related]

  • 8. Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
    de Monteynard LA, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Mahamat A, Dray-Spira R, Simon A, Costagliola D, Abgrall S, FHDH-ANRS CO4.
    PLoS One; 2018 Aug 04; 13(10):e0205385. PubMed ID: 30379870
    [Abstract] [Full Text] [Related]

  • 9. Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir.
    Abgrall S, Yeni PG, Bouchaud O, Costagliola D, Clinical Epidemiology Group from the French Hospital Database on HIV.
    AIDS; 2006 Oct 24; 20(16):2099-106. PubMed ID: 17053356
    [Abstract] [Full Text] [Related]

  • 10. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002.
    Lampe FC, Gatell JM, Staszewski S, Johnson MA, Pradier C, Gill MJ, de Lazzari E, Dauer B, Youle M, Fontas E, Krentz HB, Phillips AN.
    Arch Intern Med; 2006 Mar 13; 166(5):521-8. PubMed ID: 16534038
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HIV-1 subtypes and response to combination antiretroviral therapy in Europe.
    Bannister WP, Ruiz L, Loveday C, Vella S, Zilmer K, Kjaer J, Knysz B, Phillips AN, Mocroft A, EuroSIDA Study Group.
    Antivir Ther; 2006 Mar 13; 11(6):707-15. PubMed ID: 17310815
    [Abstract] [Full Text] [Related]

  • 13. Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.
    Pistone T, Ouattara E, Gabillard D, Lele N, Duvignaud A, Cordel H, Malvy D, Bouchaud O, Abgrall S, ANRS VIHVO Study Group.
    Travel Med Infect Dis; 2019 Mar 13; 29():40-47. PubMed ID: 30951905
    [Abstract] [Full Text] [Related]

  • 14. A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
    Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, Walmsley SL, Smieja M, Bayoumi A, Mills E, Hogg RS, CANOC Collaboration.
    J Acquir Immune Defic Syndr; 2010 Dec 13; 55(4):451-9. PubMed ID: 21105259
    [Abstract] [Full Text] [Related]

  • 15. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load.
    Thørner LW, Erikstrup C, Harritshøj LH, Larsen MH, Kronborg G, Pedersen C, Larsen CS, Pedersen G, Gerstoft J, Obel N, Ullum H.
    Infect Genet Evol; 2016 Jul 13; 41():185-190. PubMed ID: 27083073
    [Abstract] [Full Text] [Related]

  • 16. Predictors of faster virological suppression in early treated infants with perinatal HIV from Europe and Thailand.
    European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) and Early-treated Perinatally HIV-infected Individuals: Improving Childrenʼs Actual Life with Novel Immunotherapeutic Strategies (EPIICAL) study groups.
    AIDS; 2019 Jun 01; 33(7):1155-1165. PubMed ID: 30741823
    [Abstract] [Full Text] [Related]

  • 17. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
    Hailu GG, Wasihun AG.
    BMC Infect Dis; 2021 Jun 12; 21(1):561. PubMed ID: 34118891
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.
    Cardoso SW, Luz PM, Velasque L, Torres TS, Tavares IC, Ribeiro SR, Moreira RI, Veloso VG, Moore RD, Grinsztejn B.
    BMC Infect Dis; 2014 Dec 19; 14():699. PubMed ID: 25523385
    [Abstract] [Full Text] [Related]

  • 19. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
    Saracino A, Lorenzini P, Lo Caputo S, Girardi E, Castelli F, Bonfanti P, Rusconi S, Caramello P, Abrescia N, Mussini C, Monno L, d'Arminio Monforte A, ICONA Foundation Study Group.
    Clin Microbiol Infect; 2016 Mar 19; 22(3):288.e1-8. PubMed ID: 26551839
    [Abstract] [Full Text] [Related]

  • 20. Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
    Chaix ML, Seng R, Frange P, Tran L, Avettand-Fenoël V, Ghosn J, Reynes J, Yazdanpanah Y, Raffi F, Goujard C, Rouzioux C, Meyer L, ANRS PRIMO Cohort Study Group.
    Clin Infect Dis; 2013 Mar 19; 56(6):880-7. PubMed ID: 23223603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.